Skip to content

Electroacupuncture for Elder Adults with Mild Cognitive Impairment (MCI): a Randomized Patient and Assessor-Blind Sham-Controlled Trial

Electroacupuncture for Elder Adults with Mild Cognitive Impairment (MCI): a Randomized Patient and Assessor-Blind Sham-Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002414
Enrollment
Unknown
Registered
2012-08-09
Start date
2012-09-03
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive impairment

Interventions

Treatment:Electroacupuncture
Control:Sham Electroacupunture

Sponsors

Food and health Bureau
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. subjects should have subjective memory complaints as examined by an abbreviated memory inventory for the Chinese; 2. objective memory impairment is measured by a composite memory score derived from the Alzheimer's Disease Assessment Scale-Cognitive subscal (ADAS-Cog), MCI subjects hsould have a memeory score of <=1.5 SD of the not demented subjects (CDR0); 3. the subjects should have relatively intact activities of daily living; 4. absence of AD.

Exclusion criteria

Exclusion criteria: The individuals with a diagnosis of dementia or AD, notable cognitive impairment (score of 23 or less as evidenced by CMMSE), current psychiatric disorder (e.g. depressive episode), malignancy, clinical history of stroke associated with permanent disability, history of alcohol or drug abuse, or history of bleeding disorder, or currently acupuncture/taking drug for cognitive problems, or currently treated with medications, affecting cognition or other serious illnesses e.g. clinically significant, active gastrointestinal, renal, hepatic, respiratory, infectious, endocrine, or cardiovascular system disease will be considered as ineligible. The illiteracy or patients who meet difficulty in reading and understanding study questionnaire are also excluded.

Design outcomes

Primary

MeasureTime frame
cognitive decline as measured by the Chinese version of Alzheimer Disease Assessment Scale-Cognitive;mini-mental state examination, category fluency test and the Short Form 12 (SF12);

Countries

China

Contacts

Public ContactProf. Leung Wing Nang, Albert
awnleung@cuhk.edu.hk+852 3943 1294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 17, 2026